| Detected | Trial | Change |
|---|---|---|
| 2026-05-27 | NCT06290128 A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory… |
Trial sites expanded: 125 -> 128 locations |
| 2026-05-19 | NCT06290141 A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of… |
Trial sites expanded: 118 -> 122 locations |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT06290128 | A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory… | Chronic Inflammatory Demyelinating Polyradiculoneuropathy | Recruiting |
| NCT06290141 | A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of… | Chronic Inflammatory Demyelinating Polyneuropathy | Recruiting |
| NCT06859099 | Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDP | Polyneuropathy, Inflammatory Demyelinating, Chronic | Enrolling by Invitation |
| Phase 2 | |||
| NCT05156710 | BIVV020 (SAR445088) in Prevention and Treatment of Antibody-mediated Rejection (AMR) | Transplant Rejection | Active, Not Recruiting |